FYERS
Home
/
Stocks
/
Profit Loss
/
IOL Chemicals And Pharmaceuticals Profit & Loss

IOL Chemicals And Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
₹756 Cr₹619 Cr₹580 Cr₹568 Cr₹552 Cr₹528 Cr₹523 Cr₹526 Cr₹502 Cr₹504 Cr₹520 Cr₹545 Cr₹563 Cr₹587 Cr₹523 Cr₹541 Cr₹565 Cr₹572 Cr
₹8 Cr₹2 Cr₹5 Cr₹7 Cr₹7 Cr₹5 Cr₹4 Cr₹6 Cr₹7 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹9 Cr₹7 Cr₹5 Cr₹5 Cr₹7 Cr
₹764 Cr₹621 Cr₹586 Cr₹574 Cr₹559 Cr₹532 Cr₹527 Cr₹532 Cr₹510 Cr₹511 Cr₹529 Cr₹552 Cr₹570 Cr₹596 Cr₹530 Cr₹546 Cr₹570 Cr₹579 Cr
₹674 Cr₹547 Cr₹543 Cr₹530 Cr₹509 Cr₹484 Cr₹495 Cr₹502 Cr₹468 Cr₹471 Cr₹492 Cr₹497 Cr₹505 Cr₹504 Cr₹493 Cr₹521 Cr₹520 Cr₹538 Cr
₹112 Cr₹94 Cr₹63 Cr₹64 Cr₹70 Cr₹67 Cr₹51 Cr₹48 Cr₹58 Cr₹57 Cr₹53 Cr₹71 Cr₹80 Cr₹104 Cr₹49 Cr₹37 Cr₹61 Cr₹52 Cr
₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr
₹87 Cr₹71 Cr₹28 Cr₹40 Cr₹46 Cr₹45 Cr₹28 Cr₹26 Cr₹40 Cr₹37 Cr₹32 Cr₹51 Cr₹61 Cr₹87 Cr₹33 Cr₹22 Cr₹47 Cr₹39 Cr
₹64 Cr₹53 Cr₹21 Cr₹30 Cr₹34 Cr₹31 Cr₹21 Cr₹19 Cr₹30 Cr₹28 Cr₹23 Cr₹38 Cr₹46 Cr₹65 Cr₹24 Cr₹16 Cr₹35 Cr₹30 Cr

Share Price Live Stats

Open (₹)197.00
Volume (₹)43.85 L
High (₹)204.98
Upper Circuit235.71
Low (₹)192.50
Lower Circuit157.15
Prev Close196.43
52W High (₹)204.98
Price200.36
52W Low (₹)67.19

Share Market Cap & Key Ratios Overview

M.Cap (₹)5753.14 Cr
Div. Yield (%)0.10
PE Ratio34.22
Debt to Equity0.07
Price to Book1.19
Book Value61.27
EPS (TTM)5.73
Face Value2.00
ROE (%)7.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
IOLCPNSE
LTP
1W Low
1W High
Market cap (₹)
1899.7-20.3 (-1.06%)
1896.80
1984.80
4,56,833Cr
9149-90 (-0.97%)
9087
9467
2,45,426Cr
4828.5-221.5 (-4.39%)
4827
5066
1,87,320Cr
1129.6-61.4 (-5.16%)
1125.10
1187
1,13,217Cr
1377.9-45.6 (-3.20%)
1376
1426.10
1,12,212Cr
1847-91.5 (-4.72%)
1811.70
1949
1,01,155Cr
2110.5-61 (-2.81%)
2110.30
2192
97,626Cr
2335.9-47 (-1.97%)
2334
2419.20
96,859Cr
1158.4-19.6 (-1.66%)
1154.40
1179.90
96,406Cr
1653.6+8.3 (0.50%)
1622.60
1717
93,614Cr
200.36+5.41 (2.78%)
186
204.98
5,753Cr

Key Highlights of IOL Chemicals And Pharmaceuticals Ltd’s P&L

In 2026-03-31, IOL Chemicals And Pharmaceuticals Ltd reported total revenue of ₹2340.44Cr, compared with ₹2101.62Cr in 2025-03-31, reflecting IOL Chemicals And Pharmaceuticals Ltd turnover.

Depreciation was ₹80.23Cr and finance costs were ₹14.55Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹184.36Cr in 2026-03-31 as compared to ₹137.96Cr in 2025-03-31.

Net Profit (PAT) was ₹137.64Cr in 2026-03-31 compared with ₹101.07Cr in 2025-03-31.

Earnings per share (EPS) were ₹4.69 in 2026-03-31, compared with ₹3.44 in 2025-03-31.